In the wake of recent developments in the field of cell therapy, bioprinter vendors are seeking to market to more sophisticated researchers.
To better engage students, professors are integrating active learning methods into their biomedical classes.
Gain access to free tools and resources from AABME, an initiative designed to stimulate biomedical innovation by bringing together and providing resources to the biomedical engineering community.
Researchers at the Southwest Research Institute now are tackling the challenge of 3D-printing nonbiological parts that mimic the actual physical properties of human tissue.
Binil Starly discusses his work on culturing stem cells in 3D microgels using a low shear stress rotating wheel-type bioreactor. The study poses microgels as a viable option for growing millions to billions of the therapeutic stem cells required for regenerative medicine.
Canada and GE Lifesciences are teaming up on a $40 million center to drive innovation in cell therapy manufacturing and scale-up.
Before they can deliver cell therapy products to large numbers of patients, engineers must find a way to manufacture them safely, reliably, and cost-effectively. Now, a team of bioengineers have a manufacturing paradigm they think can improve that process.
Sign up for AABME’s white paper series to receive the next white paper authored by Jedediah Lewis, Dr. Alyssa Ward, Dr. Greg Fahy, Mark Severs, Dr. Boris Schmalz, and Dr. Gloria Elliott.
We are almost ready to share the next AABME white paper, Genome Editing and Biomanufacturing, by Gang Bao, a pioneer in nanomedicine, molecular imaging, and the emerging area of genome editing.
Researchers have developed a way to manufacture microrobots solely from biomaterials that have freely moving parts, can be safely implanted in the body, and can be activated wirelessly.
A new model from the U.K. will allow amputees to pick up their foot and walk up slopes.